MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium… Read more
MedCap AB (publ) (MCAP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.104x
Based on the latest financial reports, MedCap AB (publ) (MCAP) has a cash flow conversion efficiency ratio of 0.104x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr151.50 Million) by net assets (Skr1.46 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MedCap AB (publ) - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how MedCap AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MedCap AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedCap AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MorningStar Partners, L.P.
NYSE:TXO
|
0.038x |
|
Jiangxi Ganneng Co Ltd
SHE:000899
|
0.125x |
|
Pell Bio-Med Technology Co., Ltd.
TW:6949
|
-0.061x |
|
Top Resource Conservation Engineering Co Ltd
SHE:300332
|
0.021x |
|
Si-Bone Inc
NASDAQ:SIBN
|
0.014x |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
0.016x |
|
Senton Energy Co. Ltd. A
SHE:001331
|
N/A |
|
Kunshan Guoli Electronic Technology Co Ltd
SHG:688103
|
0.012x |
Annual Cash Flow Conversion Efficiency for MedCap AB (publ) (2007–2025)
The table below shows the annual cash flow conversion efficiency of MedCap AB (publ) from 2007 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.46 Billion | Skr342.70 Million | 0.235x | -15.94% |
| 2024-12-31 | Skr1.29 Billion | Skr360.00 Million | 0.279x | +25.89% |
| 2023-12-31 | Skr1.03 Billion | Skr228.00 Million | 0.222x | +122.94% |
| 2022-12-31 | Skr858.70 Million | Skr85.50 Million | 0.100x | -40.27% |
| 2021-12-31 | Skr697.70 Million | Skr116.30 Million | 0.167x | -13.19% |
| 2020-12-31 | Skr602.00 Million | Skr115.60 Million | 0.192x | -10.50% |
| 2019-12-31 | Skr332.80 Million | Skr71.40 Million | 0.215x | -35.16% |
| 2018-12-31 | Skr273.80 Million | Skr90.60 Million | 0.331x | +224.47% |
| 2017-12-31 | Skr267.70 Million | Skr27.30 Million | 0.102x | -63.41% |
| 2016-12-31 | Skr292.29 Million | Skr81.46 Million | 0.279x | +675.70% |
| 2015-12-31 | Skr308.15 Million | Skr-14.92 Million | -0.048x | -701.63% |
| 2014-12-31 | Skr280.63 Million | Skr2.26 Million | 0.008x | +106.43% |
| 2013-12-31 | Skr221.92 Million | Skr865.00K | 0.004x | -98.02% |
| 2012-12-31 | Skr195.48 Million | Skr38.55 Million | 0.197x | +16.49% |
| 2011-12-31 | Skr169.82 Million | Skr28.75 Million | 0.169x | -0.54% |
| 2010-12-31 | Skr179.99 Million | Skr30.64 Million | 0.170x | +67.04% |
| 2009-12-31 | Skr169.94 Million | Skr17.32 Million | 0.102x | +305.17% |
| 2008-12-31 | Skr134.11 Million | Skr3.37 Million | 0.025x | +49.35% |
| 2007-12-31 | Skr127.44 Million | Skr2.15 Million | 0.017x | -- |